Skip to main content

Table 4 Correlations of average epigenome methylation with GMD expression in individual cancer categories satisfying pFDR < 0.15

From: Association of expression of epigenetic molecular factors with DNA methylation and sensitivity to chemotherapeutic agents in cancer cell lines

Cancer category GMD Spearman ρ pFDR Sample size
CLLE CSNK1E 0.8750 0.0306* 15
LAML CBX2 0.8018 0.0306* 19
PAAD CBX1 0.6606 0.0538 27
COAD/READ SIRT1 0.5506 0.0538 43
COAD/READ SUZ12 0.5471 0.0538 43
COAD/READ HELLS 0.5388 0.0538 43
CLLE CBX2 0.8036 0.0733 15
NSCLC UHRF1 0.3563 0.0766 96
LAML MECP2 0.7158 0.0845 19
PAAD EZH2 0.6172 0.0845 27
GLIOMA TET3 0.5439 0.0845 36
COAD/READ SUV39H2 0.5115 0.0845 43
CLLE DNMT3B 0.7750 0.0886 15
CLLE DNMT1 0.7643 0.1029 15
LIHC CBX1 0.7279 0.1029 17
GLIOMA PHC2 − 0.5228 0.1119 36
CLLE UHRF1 0.7393 0.1455 15
MATBCL UHRF2 0.5291 0.1455 33
NSCLC MBD1 − 0.3169 0.1455 96
  1. An asterisk (*) indicates statistically significant associations with pFDR < 0.05